Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Viridian Therapeutics
VRDN
$2.58B
| $2.02M | ﹤0.01% |
131,557
-125,979
| -49% | -$2.4M |
|
1852
Corcept Therapeutics
CORT
$11.8B
| $2.02M | ﹤0.01% |
73,986
+2,299
| +3% | +$66.5K |
|
1853
Cenovus Energy
CVE
$52.6B
| $2.01M | ﹤0.01% |
96,511
+88,508
| +1,106% | +$1.69M |
|
1854
PUT
Applied Optoelectronics
AAOI
$11B
| $2M | ﹤0.01% |
+182,600
| New | +$1.94M |
|
|
JKS
1855
JinkoSolar
JKS
$891M
| $2M | ﹤0.01% |
65,956
+58,030
| +732% | +$2.08M |
|
1856
Milestone Pharmaceuticals
MIST
$149M
| $2M | ﹤0.01% |
645,490
-155,286
| -19% | -$483K |
|
1857
iShares Core MSCI Emerging Markets ETF
IEMG
$155B
| $2M | ﹤0.01% |
42,016
-39,307
| -48% | -$1.95M |
|
1858
Unisys
UIS
$214M
| $1.99M | ﹤0.01% |
577,712
+389,481
| +207% | +$1.65M |
|
1859
SLM Corp
SLM
$5.13B
| $1.99M | ﹤0.01% |
146,110
-12,514
| -8% | -$188K |
|
1860
Omnicell
OMCL
$1.68B
| $1.99M | ﹤0.01% |
44,179
-75,690
| -63% | -$4.59M |
|
1861
MannKind Corp
MNKD
$1.31B
| $1.98M | ﹤0.01% |
480,560
-136,470
| -22% | -$613K |
|
1862
Werner Enterprises
WERN
$2.24B
| $1.98M | ﹤0.01% |
50,870
+5,580
| +12% | +$239K |
|
1863
Advanced Energy
AEIS
$13.1B
| $1.98M | ﹤0.01% |
19,167
-8,951
| -32% | -$1M |
|
1864
Ziff Davis
ZD
$2.05B
| $1.97M | ﹤0.01% |
30,991
-6,215
| -17% | -$426K |
|
1865
Modine Manufacturing
MOD
$10.4B
| $1.97M | ﹤0.01% |
43,116
+18,295
| +74% | +$767K |
|
1866
Alamos Gold
AGI
$13.9B
| $1.97M | ﹤0.01% |
174,473
+14,987
| +9% | +$180K |
|
1867
Stem
STEM
$53.9M
| $1.97M | ﹤0.01% |
23,228
-6,529
| -22% | -$746K |
|
|
CWEN.A
1868
DELISTED
Clearway Energy Class A
CWEN.A
| $1.97M | ﹤0.01% |
98,716
-2,337
| -2% | -$56K |
|
1869
Hecla Mining
HL
$11.2B
| $1.96M | ﹤0.01% |
502,552
+273,549
| +119% | +$1.31M |
|
1870
Hims & Hers Health
HIMS
$7.25B
| $1.96M | ﹤0.01% |
311,321
-274,939
| -47% | -$2.04M |
|
1871
JetBlue
JBLU
$2.25B
| $1.95M | ﹤0.01% |
424,972
+91,403
| +27% | +$601K |
|
1872
PUT
Biogen
BIIB
$30.3B
| $1.95M | ﹤0.01% |
7,600
-50,200
| -87% | -$13.4M |
|
|
BCPC
1873
Balchem Corp
BCPC
$5.73B
| $1.95M | ﹤0.01% |
15,703
-1,159
| -7% | -$154K |
|
1874
Varex Imaging
VREX
$524M
| $1.94M | ﹤0.01% |
103,319
+57,656
| +126% | +$1.21M |
|
1875
Fomento Económico Mexicano
FMX
$41.9B
| $1.94M | ﹤0.01% |
17,782
+11,204
| +170% | +$1.24M |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.